Compare Alcon AG (ALC) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Snowflake Inc — how do they compare? Alcon AG trades at $73.63 (market cap $36.44B), while Snowflake Inc trades at $335 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 3.2× Alcon AG's market cap, and Alcon AG pays a 0.48% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals.
| ALC | SNOW | |
|---|---|---|
Market Cap | $36.44B | $116.01B |
Sector | Health | Technology |
52-Week High | $90.12 | $334.70 |
52-Week Low | $62.02 | $121.11 |
Enterprise Value | $40.28B | $115.82B |
Dividend Yield | 0.48% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.525, down 0.14% on the day, with a bullish technical signal from moving averages and positive analyst sentiment. Recent Q2 2026 earnings beat estimates, with revenue of $10.4 billion in 2025 and a net income margin of 5.92%. The company raised its 2026 profitability outlook, citing tariff relief and strong product launches.
The stock offers a 17.9% upside to the consensus price target of $86.67, supported by bullish analyst ratings and improving cash flow trends. Key risks include elevated P/E valuation at 57.52 and potential macroeconomic pressures on medical device demand. Earnings growth and execution on new products remain critical for sustained momentum.
Snowflake trades at $339.00, up 1.28% with bullish technical signals and strong analyst support (81% buy ratings). The company shows impressive revenue growth from $1.2B in 2022 to $3.6B in 2025, though remains unprofitable with a -23.79% net margin. Recent earnings beats and AI platform expansions drive optimism, but premium valuation at 22.66x P/S ratio presents risk.
Outlook remains positive with AI data cloud leadership and 30% revenue growth guidance, but investors face valuation concerns and persistent losses. Key catalysts include Q2 2026 earnings on September 2nd and enterprise AI adoption trends. The stock trades near resistance at $341 with consensus price target of $302.18 suggesting limited near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
